×
About 193 results

ALLMedicine™ First-degree Atrioventricular Block Center

Research & Reviews  54 results

Acute echocardiographic and hemodynamic response to his-bundle pacing in patients with ...
https://doi.org/10.1111/anec.12954
Annals of Noninvasive Electrocardiology : the Official Jo... Loring Z, Holmqvist F et. al.

Apr 22nd, 2022 - Atrial pacing and right ventricular (RV) pacing are both associated with adverse outcomes among patients with first-degree atrioventricular block (1°AVB). His-bundle pacing (HBP) provides physiological activation of the ventricle and may be able t...

Prognostic significance of first-degree atrioventricular block in a large Asian populat...
https://doi.org/10.1136/bmjopen-2022-062005
BMJ Open; Liu M, Du Z et. al.

Apr 6th, 2022 - To investigate the prognostic significance of first-degree atrioventricular block (AVB) in Asian populations. Participants (N=9634) from the Northeast China Rural Cardiovascular Health Study were included. The first-degree AVB was defined as PR (f...

Brugada pattern as part of the electrocardiographic abnormalities in hyperkalemia: A ca...
https://doi.org/10.1016/j.ajem.2022.02.048
The American Journal of Emergency Medicine; Klafe LH, Willes J et. al.

Mar 8th, 2022 - A 78-year-old man presented to the emergency department with a 10-day history of diarrhea and presyncope. His electrocardiogram showed a type-1 Brugada pattern but also a first-degree atrioventricular block, right bundle branch block, and peaked a...

Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospecti...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358550
BMC Infectious Diseases; Chen Z, Liu A et. al.

Aug 14th, 2021 - Since the COVID-19 pandemic, several therapeutic agents have been used in COVID-19 management. However, the results were controversial. Here, we aimed to evaluate the efficacy and safety of hydroxychloroquine (HCQ)/chloroquine (CQ) in COVID-19. We...

Cardiac effects of rapid intravenous loading of lacosamide in patients with epilepsy.
https://doi.org/10.1016/j.eplepsyres.2021.106710
Epilepsy Research; Kim HK, Lee H et. al.

Jul 16th, 2021 - Lacosamide (LCM) is a new antiseizure medication, and intravenous (IV) loading of LCM is recently used against status epilepticus. IV loading of LCM is usually well-tolerated; however, there are concerns about LCM-induced serious adverse cardiac e...

see more →

Drugs  12 results see all →

Clinicaltrials.gov  1 results

ReachPR Trial Resynchronization Therapy in Heart Failure Patients With Prolonged PR Interval
https://clinicaltrials.gov/ct2/show/NCT03973944

Aug 14th, 2019 - Rationale: Prolongation of the electrocardiographic PR interval (PR interval > 200ms; also known as first-degree atrioventricular block) is frequently encountered in clinical practice and is generally considered as a benign sign. However, there is...

see more →

News  10 results

Ibrutinib/Rituximab Combo Represents Effective Chemo-Free Option for Elderly Patients with MCL
https://www.onclive.com/view/ibrutinib-rituximab-combo-represents-effective-chemo-free-option-for-elderly-patients-with-mcl

Jan 14th, 2022 - The combination of ibrutinib (Imbruvica) and rituximab (Rituxan) produced a high overall response rate (ORR) and durable survival in elderly patients with mantle cell lymphoma (MCL), according to data from a phase 2 ENRICH trial (NCT0180567) publi...

One Aducanumab Patient, Six Brain Edema Episodes
https://www.medpagetoday.com/neurology/alzheimersdisease/95523

Nov 8th, 2021 - A man treated with the recently approved Alzheimer's drug aducanumab (Aduhelm) had six amyloid-related imaging abnormality (ARIA) episodes, researchers reported. Over 44 months in a long-term extension study, the Alzheimer's disease patient had re...

Relapsing MS: Ozanimod Tops Fingolimod in Benefit-Risk Profile
https://www.mdedge.com/neurology/msresourcecenter/article/217365/multiple-sclerosis/relapsing-ms-ozanimod-tops-fingolimod?channel=251

Feb 14th, 2020 - Key clinical point: Ozanimod has a superior benefit-risk profile compared with fingolimod for the treatment of relapsing multiple sclerosis (RMS). Major finding: Compared with fingolimod, ozanimod was associated with lower rates of conduction abno.

Hypothermia and severe first-degree heart block
https://www.mdedge.com/ccjm/article/155174/cardiology/hypothermia-and-severe-first-degree-heart-block?channel=162
Kevin Bryan Uy Lo, MD, Alison Nelson, MD

Jan 2nd, 2018 - A 96-year-old woman with hypertension, diabetes,    and dementia was found unresponsive in her nursing home and was transferred to the hospital. At presentation to the hospital, her blood pressure was 76/43 mm Hg, heart rate 42 beats per minute, r.

A 35-Year-Old Man With Palpitations and Dizziness
https://reference.medscape.com/viewarticle/868040_6

Aug 31st, 2016 - Question 1 of 2 You admit a patient from the emergency department to the medicine service. He presents with palpitations, Bell palsy, and right knee synovitis. Synovial fluid analysis reveals leukocytosis. The patient states he went hiking in Verm...

see more →